Transcription factor 7-like 2 regulates β-cell survival and function in human pancreatic islets

Luan Shu, Nadine S. Sauter, Fabienne T. Schulthess, Aleksey V Matveyenko, Jose Oberholzer, Kathrin Maedler

Research output: Contribution to journalArticle

196 Citations (Scopus)

Abstract

OBJECTIVE-Type 2 diabetes is characterized by impaired insulin secretion in response to increased metabolic demand. This defect in β-cell compensation seems to result from the interplay between environmental factors and genetic predisposition. Genome-wide association studies reveal that common variants in transcription factor 7-like 2 (TCF7L2) are associated with increased risk of type 2 diabetes. The aim of the present study was to establish whether TCF7L2 plays a role in β-cell function and/or survival. RESEARCH DESIGN AND METHODS- To investigate the effects of TCFL7L2 depletion, isolated islets were exposed to TCF7L2 small interfering RNA (siRNA) versus scrambled siRNA, and β-cell survival and function were examined. For TCF7L2 overexpression, islets were cultured in glucose concentrations of 5.5-33.3 mmol/1 and the cytokine mix interleukin-1β/γ-interferon with or without overexpression of TCF7L2. Subsequently, glucose-stimulated insulin secretion (GSIS), β-cell apoptosis [by transferase-mediated dUTP nick-end labeling assay and Western blotting for poly(ADP-ribose) polymerase and Caspase-3 cleavage], and β-cell proliferation (by Ki67 immunostaining) were analyzed. RESULTS-Depleting TCF7L2 by siRNA resulted in a 5.1-fold increase in β-cell apoptosis, 2.2-fold decrease in β-cell proliferation (P < 0.001), and 2.6-fold decrease in GSIS (P < 0.01) in human islets. Similarly, loss of TCF7L2 resulted in impaired β-cell function in mouse islets. In contrast, overexpression of TCF7L2 protected islets from glucose and cytokine-induced apoptosis and impaired function. CONCLUSIONS-TCF7L2 is required for maintaining GSIS and β-cell survival. Changes in the level of active TCF7L2 in β-cells from carriers of at-risk allele may be the reason for defective insulin secretion and progression of type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)645-653
Number of pages9
JournalDiabetes
Volume57
Issue number3
DOIs
StatePublished - Mar 2008
Externally publishedYes

Fingerprint

T Cell Transcription Factor 1
Islets of Langerhans
Cell Survival
Insulin
Glucose
Type 2 Diabetes Mellitus
Small Interfering RNA
Apoptosis
Cell Proliferation
Cytokines
Poly(ADP-ribose) Polymerases
Genome-Wide Association Study
Genetic Predisposition to Disease
Transferases
Interleukin-1
Caspase 3
Interferons

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Transcription factor 7-like 2 regulates β-cell survival and function in human pancreatic islets. / Shu, Luan; Sauter, Nadine S.; Schulthess, Fabienne T.; Matveyenko, Aleksey V; Oberholzer, Jose; Maedler, Kathrin.

In: Diabetes, Vol. 57, No. 3, 03.2008, p. 645-653.

Research output: Contribution to journalArticle

Shu, L, Sauter, NS, Schulthess, FT, Matveyenko, AV, Oberholzer, J & Maedler, K 2008, 'Transcription factor 7-like 2 regulates β-cell survival and function in human pancreatic islets', Diabetes, vol. 57, no. 3, pp. 645-653. https://doi.org/10.2337/db07-0847
Shu, Luan ; Sauter, Nadine S. ; Schulthess, Fabienne T. ; Matveyenko, Aleksey V ; Oberholzer, Jose ; Maedler, Kathrin. / Transcription factor 7-like 2 regulates β-cell survival and function in human pancreatic islets. In: Diabetes. 2008 ; Vol. 57, No. 3. pp. 645-653.
@article{481fb50b3ac1470f9886bd91516c6e1d,
title = "Transcription factor 7-like 2 regulates β-cell survival and function in human pancreatic islets",
abstract = "OBJECTIVE-Type 2 diabetes is characterized by impaired insulin secretion in response to increased metabolic demand. This defect in β-cell compensation seems to result from the interplay between environmental factors and genetic predisposition. Genome-wide association studies reveal that common variants in transcription factor 7-like 2 (TCF7L2) are associated with increased risk of type 2 diabetes. The aim of the present study was to establish whether TCF7L2 plays a role in β-cell function and/or survival. RESEARCH DESIGN AND METHODS- To investigate the effects of TCFL7L2 depletion, isolated islets were exposed to TCF7L2 small interfering RNA (siRNA) versus scrambled siRNA, and β-cell survival and function were examined. For TCF7L2 overexpression, islets were cultured in glucose concentrations of 5.5-33.3 mmol/1 and the cytokine mix interleukin-1β/γ-interferon with or without overexpression of TCF7L2. Subsequently, glucose-stimulated insulin secretion (GSIS), β-cell apoptosis [by transferase-mediated dUTP nick-end labeling assay and Western blotting for poly(ADP-ribose) polymerase and Caspase-3 cleavage], and β-cell proliferation (by Ki67 immunostaining) were analyzed. RESULTS-Depleting TCF7L2 by siRNA resulted in a 5.1-fold increase in β-cell apoptosis, 2.2-fold decrease in β-cell proliferation (P < 0.001), and 2.6-fold decrease in GSIS (P < 0.01) in human islets. Similarly, loss of TCF7L2 resulted in impaired β-cell function in mouse islets. In contrast, overexpression of TCF7L2 protected islets from glucose and cytokine-induced apoptosis and impaired function. CONCLUSIONS-TCF7L2 is required for maintaining GSIS and β-cell survival. Changes in the level of active TCF7L2 in β-cells from carriers of at-risk allele may be the reason for defective insulin secretion and progression of type 2 diabetes.",
author = "Luan Shu and Sauter, {Nadine S.} and Schulthess, {Fabienne T.} and Matveyenko, {Aleksey V} and Jose Oberholzer and Kathrin Maedler",
year = "2008",
month = "3",
doi = "10.2337/db07-0847",
language = "English (US)",
volume = "57",
pages = "645--653",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Transcription factor 7-like 2 regulates β-cell survival and function in human pancreatic islets

AU - Shu, Luan

AU - Sauter, Nadine S.

AU - Schulthess, Fabienne T.

AU - Matveyenko, Aleksey V

AU - Oberholzer, Jose

AU - Maedler, Kathrin

PY - 2008/3

Y1 - 2008/3

N2 - OBJECTIVE-Type 2 diabetes is characterized by impaired insulin secretion in response to increased metabolic demand. This defect in β-cell compensation seems to result from the interplay between environmental factors and genetic predisposition. Genome-wide association studies reveal that common variants in transcription factor 7-like 2 (TCF7L2) are associated with increased risk of type 2 diabetes. The aim of the present study was to establish whether TCF7L2 plays a role in β-cell function and/or survival. RESEARCH DESIGN AND METHODS- To investigate the effects of TCFL7L2 depletion, isolated islets were exposed to TCF7L2 small interfering RNA (siRNA) versus scrambled siRNA, and β-cell survival and function were examined. For TCF7L2 overexpression, islets were cultured in glucose concentrations of 5.5-33.3 mmol/1 and the cytokine mix interleukin-1β/γ-interferon with or without overexpression of TCF7L2. Subsequently, glucose-stimulated insulin secretion (GSIS), β-cell apoptosis [by transferase-mediated dUTP nick-end labeling assay and Western blotting for poly(ADP-ribose) polymerase and Caspase-3 cleavage], and β-cell proliferation (by Ki67 immunostaining) were analyzed. RESULTS-Depleting TCF7L2 by siRNA resulted in a 5.1-fold increase in β-cell apoptosis, 2.2-fold decrease in β-cell proliferation (P < 0.001), and 2.6-fold decrease in GSIS (P < 0.01) in human islets. Similarly, loss of TCF7L2 resulted in impaired β-cell function in mouse islets. In contrast, overexpression of TCF7L2 protected islets from glucose and cytokine-induced apoptosis and impaired function. CONCLUSIONS-TCF7L2 is required for maintaining GSIS and β-cell survival. Changes in the level of active TCF7L2 in β-cells from carriers of at-risk allele may be the reason for defective insulin secretion and progression of type 2 diabetes.

AB - OBJECTIVE-Type 2 diabetes is characterized by impaired insulin secretion in response to increased metabolic demand. This defect in β-cell compensation seems to result from the interplay between environmental factors and genetic predisposition. Genome-wide association studies reveal that common variants in transcription factor 7-like 2 (TCF7L2) are associated with increased risk of type 2 diabetes. The aim of the present study was to establish whether TCF7L2 plays a role in β-cell function and/or survival. RESEARCH DESIGN AND METHODS- To investigate the effects of TCFL7L2 depletion, isolated islets were exposed to TCF7L2 small interfering RNA (siRNA) versus scrambled siRNA, and β-cell survival and function were examined. For TCF7L2 overexpression, islets were cultured in glucose concentrations of 5.5-33.3 mmol/1 and the cytokine mix interleukin-1β/γ-interferon with or without overexpression of TCF7L2. Subsequently, glucose-stimulated insulin secretion (GSIS), β-cell apoptosis [by transferase-mediated dUTP nick-end labeling assay and Western blotting for poly(ADP-ribose) polymerase and Caspase-3 cleavage], and β-cell proliferation (by Ki67 immunostaining) were analyzed. RESULTS-Depleting TCF7L2 by siRNA resulted in a 5.1-fold increase in β-cell apoptosis, 2.2-fold decrease in β-cell proliferation (P < 0.001), and 2.6-fold decrease in GSIS (P < 0.01) in human islets. Similarly, loss of TCF7L2 resulted in impaired β-cell function in mouse islets. In contrast, overexpression of TCF7L2 protected islets from glucose and cytokine-induced apoptosis and impaired function. CONCLUSIONS-TCF7L2 is required for maintaining GSIS and β-cell survival. Changes in the level of active TCF7L2 in β-cells from carriers of at-risk allele may be the reason for defective insulin secretion and progression of type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=40949141938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949141938&partnerID=8YFLogxK

U2 - 10.2337/db07-0847

DO - 10.2337/db07-0847

M3 - Article

VL - 57

SP - 645

EP - 653

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 3

ER -